CCL5 and rheumatoid arthritis: Synergistic activation of RA-SFs occurs with NOD-1 and TLR2 ligands or NOD-1 and TLR4 ligands, leading to the secretion of IL-6, CCL5, and MMPs, which promote RA progression [73].